Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
复制标题
垂体生长激素腺瘤产生生长激素(GH)释放激素(GHRH),且血浆 GHRH 浓度升高:GHRH 自分泌和旁分泌调节 GH 分泌的模型。
DOI:
10.1210/jcem.84.9.6008
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
T. Nagashima
中科院分区:
文献类型:
--
作者:
A. Matsuno;H. Katakami;N. Sanno;Y. Ogino;R. Osamura;S. Matsukura;N. Shimizu;T. Nagashima
An acromegalic patient with a pituitary somatotroph adenoma associated with an extremely elevated plasma GHRH concentration is presented. The preoperatively high concentration of plasma GHRH returned to the normal level after successful removal of the adenoma. GHRH production and GHRH gene expression were confirmed in the adenoma by studies including immunohistochemistry and in situ hybridization. Expression of GHRH receptor messenger ribonucleic acid was verified by in situ hybridization. Immunohistochemical double staining for GH and GHRH revealed their colocalization in single adenoma cells. These findings confirmed the autocrine or paracrine regulation of GH production by endogenous GHRH from the adenoma cells. GHRH synthesis in the pituitary gland has recently been demonstrated, however, there have been no previous reports of a GHRH-producing pituitary somatotroph adenoma associated with an elevated plasma GHRH concentration. The existence of this GHRH-producing adenoma suggests a possible role of locally generated GHRH in the progression of somatotroph adenomas, i.e. the monoclonally established somatotroph adenomas develop further under the influence of locally produced GHRH. The demonstration of GHRH production by this somatotroph adenoma is of importance in clarifying the autocrine or paracrine regulation of GH production and the progression of human somatotroph adenomas.
登录
查看更多内容
DOI:
10.1172/jci112490
发表时间:
1986
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Katakami,H;Downs,TR;Frohman,LA
通讯作者:
Frohman,LA
影响因子:
4.8
作者:
Aronin,N;Morency,K;Leeman,SE;Braverman,LE;Coslovsky,R
通讯作者:
Coslovsky,R
DOI:
10.1172/jci112679
发表时间:
1986
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Frohman,LA;Downs,TR;Williams,TC;Heimer,EP;Pan,YC;Felix,AM
通讯作者:
Felix,AM
DOI:
10.1210/jcem-56-2-417
发表时间:
1983
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Webb,CB;Thominet,JL;Frohman,LA
通讯作者:
Frohman,LA
DOI:
10.1210/mend-1-4-300
发表时间:
1987
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
Billestrup,N;Mitchell,RL;Vale,W;Verma,IM
通讯作者:
Verma,IM